Pdt Partners, LLC Black Diamond Therapeutics, Inc. Transaction History

Pdt Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.5 - $3.63 $99,252 - $240,189	-66,168 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.66 - $5.61 $20,928 - $44,139	-7,868 Reduced 10.63%	66,168 $183,000
Q4 2021 Feb 14, 2022	SELL	$5.18 - $8.48 $144,231 - $236,117	-27,844 Reduced 27.33%	74,036 $395,000
Q3 2021 Nov 15, 2021	SELL	$8.46 - $12.42 $85,336 - $125,280	-10,087 Reduced 9.01%	101,880 $862,000
Q2 2021 Aug 16, 2021	BUY	$12.19 - $28.17 $539,078 - $1.25 Million	44,223 Added 65.28%	111,967 $1.37 Million
Q1 2021 May 17, 2021	BUY	$22.23 - $34.75 $950,199 - $1.49 Million	42,744 Added 170.98%	67,744 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $441,873 - $524,790	14,994 Added 149.85%	25,000 $801,000
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $261,857 - $430,958	10,006 New	10,006 $302,000

100

47.3M

108K

24.8K

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $154M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.